Literature DB >> 15157070

Structure of the ferrous form of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis in complex with the therapeutic herbicide, NTBC.

June M Brownlee1, Kayunta Johnson-Winters, David H T Harrison, Graham R Moran.   

Abstract

Di- and triketone inhibitors of (4-hydroxyphenyl)pyruvate dioxygenase (HPPD) are both effective herbicides and therapeutics. The inhibitory activity is used to halt the production of lipophilic redox cofactors in plants and also in humans to prevent accumulation of toxic metabolic byproducts that arise from specific inborn defects of tyrosine catabolism. The three-dimensional structure of the Fe(II) form of HPPD from Streptomyces avermitilis in complex with the inhibitor 2-[2-nitro-4-(triflouromethyl)benzoyl]-1,3-cyclohexanedione (NTBC) has been determined at a resolution of 2.5 A. NTBC coordinates to the active site metal ion, located at the bottom of a wide solvent-accessible cavity in the C-terminal domain of the protein. The iron is liganded in a predominantly five-coordinate, distorted square-pyramidal arrangement in which Glu349, His187, and His270 are protein-derived ligands and two other ligands are from the 5' and 7' oxygens of NTBC. There is a low-occupancy water molecule in the sixth coordination site in one of the protomers. The distance to His270 is unusually long at 2.5 A, and its orientation is somewhat distorted from ideal ligand geometry to within 2.8 A of the inhibitor nitro group. In contrast to the tetrameric quartenary structure observed for HPPD from other bacterial sources, the asymmetric unit is composed of two weakly associated protomers with a buried surface area of 1266 A(2) and a total of 12 hydrogen-bonding and no electrostatic interactions. The overall tertiary structure is similar to that of HPPD from Pseudomonas fluorescens (Serre et al., (1999) Structure 7, 977-988), although the position of the C-terminal alpha-helix is dramatically shifted. This C-terminal alpha-helix provides Phe364, which in combination with Phe336 sandwiches the phenyl ring of the bound NTBC; no other significant hydrogen-bonding or charge-pairing interactions are observed. Moreover, the structure reveals that, with the exception of Val189, NTBC makes contacts to only fully conserved amino acids. The combination of bidentate metal-ion coordination and pi-stacked aromatic rings is suggestive of a binding mode for the substrate and/or a transition state, which may be the origin of the exceedingly high affinity these inhibitors have for HPPD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157070     DOI: 10.1021/bi049317s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

Review 1.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  Free energy calculations elucidate substrate binding, gating mechanism, and tolerance-promoting mutations in herbicide target 4-hydroxyphenylpyruvate dioxygenase.

Authors:  Christina E M Schindler; Eva Hollenbach; Thomas Mietzner; Klaus-Jürgen Schleifer; Martin Zacharias
Journal:  Protein Sci       Date:  2019-04-19       Impact factor: 6.725

4.  The discovery of medicines for rare diseases.

Authors:  David C Swinney; Shuangluo Xia
Journal:  Future Med Chem       Date:  2014-06       Impact factor: 3.808

5.  Structural and functional characterization of 4-hydroxyphenylpyruvate dioxygenase from the thermoacidophilic archaeon Picrophilus torridus.

Authors:  Eduard Frick; Thomas Spatzal; Stefan Gerhardt; Andreas Krämer; Oliver Einsle; Wolfgang Hüttel
Journal:  Extremophiles       Date:  2014-05-03       Impact factor: 2.395

6.  4-hydroxyphenylpyruvate dioxygenase catalysis: identification of catalytic residues and production of a hydroxylated intermediate shared with a structurally unrelated enzyme.

Authors:  Corinne Raspail; Matthieu Graindorge; Yohann Moreau; Serge Crouzy; Bertrand Lefèbvre; Adeline Y Robin; Renaud Dumas; Michel Matringe
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

7.  Transcriptome analysis of Paracoccidioides brasiliensis cells undergoing mycelium-to-yeast transition.

Authors:  Luiz R Nunes; Regina Costa de Oliveira; Daniela Batista Leite; Vivian Schmidt da Silva; Everaldo dos Reis Marques; Márcia Eliana da Silva Ferreira; Diógenes Custódio Duarte Ribeiro; Luciano Angelo de Souza Bernardes; Maria Helena S Goldman; Rosana Puccia; Luiz R Travassos; Wagner L Batista; Marina Pasetto Nóbrega; Francisco G Nobrega; Ding-Yah Yang; Carlos A de Bragança Pereira; Gustavo H Goldman
Journal:  Eukaryot Cell       Date:  2005-12

8.  Toxoflavin lyase requires a novel 1-His-2-carboxylate facial triad.

Authors:  Michael K Fenwick; Benjamin Philmus; Tadhg P Begley; Steven E Ealick
Journal:  Biochemistry       Date:  2011-01-20       Impact factor: 3.162

9.  Spectroscopic and electronic structure studies of aromatic electrophilic attack and hydrogen-atom abstraction by non-heme iron enzymes.

Authors:  Michael L Neidig; Andrea Decker; Oliver W Choroba; Fanglu Huang; Michael Kavana; Graham R Moran; Jonathan B Spencer; Edward I Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-18       Impact factor: 11.205

10.  The Interaction of Hydroxymandelate Synthase with the 4-Hydroxyphenylpyruvate Dioxygenase Inhibitor: NTBC.

Authors:  John A Conrad; Graham R Moran
Journal:  Inorganica Chim Acta       Date:  2008-03       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.